Chemical activators of Trav9n-3 are diverse and target various cellular processes to achieve activation of this protein. Forskolin, by activating adenylyl cyclase, leads to increased cellular levels of cAMP, a secondary messenger that in turn activates protein kinase A (PKA). PKA is known to phosphorylate an array of proteins, enabling the activation of Trav9n-3 through phosphorylation within its signaling network. Similarly, Dibutyryl-cAMP, a synthetic analogue of cAMP, directly stimulates PKA, fostering a conducive environment for the activation of Trav9n-3. Moreover, Phorbol 12-myristate 13-acetate (PMA) mimics diacylglycerol and robustly activates protein kinase C (PKC). PKC participates in multiple signaling cascades and can activate Trav9n-3 by phosphorylation. Anisomycin, through its role in activating stress-activated protein kinases, provides another avenue for the activation of Trav9n-3 via phosphorylation within the stress response signaling pathways.
Additionally, the intracellular calcium ion concentration is a critical regulator of numerous kinases. Ionomycin facilitates the influx of calcium, which activates calcium-dependent kinases capable of phosphorylating and thus activating Trav9n-3. Thapsigargin contributes to this process by inhibiting the SERCA pump, leading to increased cytosolic calcium levels and subsequent activation of kinases that can act on Trav9n-3. The phosphatase inhibitors Okadaic Acid and Calyculin A prevent the dephosphorylation of proteins, maintaining Trav9n-3 in a phosphorylated and active state by blocking the activity of protein phosphatases 1 and 2A. Sphingosine-1-phosphate activates its specific cell surface receptors that initiate signaling cascades culminating in the activation of Trav9n-3 through kinase pathways. Jasplakinolide, through its action on actin polymerization, may trigger the activation of cytoskeleton-associated kinases, creating a cascade that leads to the activation of Trav9n-3. Fusicoccin, engaging 14-3-3 proteins, may enhance the activation state of Trav9n-3 if it is among the effector proteins associated with 14-3-3. Lastly, Hydrogen Peroxide acts as an intracellular messenger to activate various kinases, which in turn can activate Trav9n-3 as part of redox signaling pathways. Each of these chemicals, through their distinct mechanisms, ensures the activation of Trav9n-3 via modulation of signaling pathways or cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-dependent kinases that phosphorylate and activate Trav9n-3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which is known to phosphorylate and activate proteins within the associated signaling pathway of Trav9n-3. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which could include Trav9n-3 as part of its signaling cascade. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased intracellular calcium levels, which could activate kinases that phosphorylate and activate Trav9n-3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that directly activates PKA, leading to phosphorylation and activation of Trav9n-3. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits certain protein phosphatases, leading to increased phosphorylation and activation of Trav9n-3 by kinases within its signaling pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases, which could phosphorylate and activate Trav9n-3 as part of the stress response signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Activates sphingosine-1-phosphate receptors, triggering signaling cascades that can lead to the activation of kinases which phosphorylate and activate Trav9n-3. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and can lead to the activation of signaling pathways involving cytoskeletal regulation, potentially activating kinases that phosphorylate and lead to the activation of Trav9n-3. | ||||||
Fusicoccin | 20108-30-9 | sc-200754 sc-200754A sc-200754B | 1 mg 5 mg 10 mg | $416.00 $2081.00 $4162.00 | 7 | |
Stabilizes the interaction between 14-3-3 proteins and phosphorylated effector proteins, potentially enhancing the activation state of Trav9n-3 if it is a part of the 14-3-3-binding proteins. | ||||||